44th Parl. 1st Sess.
February 14, 2022 11:00AM
Madam Speaker, I will be sharing my time with the member for York Centre.
I am very proud tonight to rise and speak on behalf of our side to Bill C-10, an act respecting certain measures related to COVID-19. I am thankful for giving the bill the attention and priority that is required.
As members are aware, we have committed through this bill to continue our support of provinces and territories, workplace and not-for-profit organizations in managing the pandemic. In particular, the bill seeks to make rapid tests readily available for the purposes of early detection of COVID-19 positive cases and mitigating the transmission of the virus. I will first speak about regulatory approval of tests.
Since the start of the pandemic, Health Canada has put in place rapid, innovative and agile measures through interim orders to ensure prompt access to medical devices and to respond to the needs of Canadians. Canada has one of the most highly regarded regulatory frameworks for medical devices in the world. Health Canada's consistent approach throughout the pandemic has ensured that testing devices available in Canada have been high performing and reliable.
Health Canada has made it a priority to review applications for COVID-19 devices that meet an urgent public health need in Canada. Manufacturers of these devices must provide sufficient data to support the intended use, including the sensitivity established for the specific test. Tests that do not meet high standards of sensitivity values are not authorized for use, and Canada is one of the few countries with minimal post-market issues, including recalls.
As of the beginning of February, in fact, Health Canada has authorized 107 testing devices, including 10 self-tests and 27 tests that can be used in a point-of-care setting. Working with our public health partners, we have identified testing technologies that are the highest priority for evaluation at this time. Additionally, based on the information available to date, the authorized tests continue to be effective in detecting variants. Canada is also taking a proactive role by contacting manufacturers of self-tests that have been authorized in other jurisdictions and inviting them to submit applications for approval in Canada, and more self-testing applications are currently under evaluation by Health Canada.
To advance regulatory approval of new COVID-19 tests, the regulator has approved over 100 clinical trials for COVID-19 products, many of which benefited from flexible approaches, ultimately helping to identify promising COVID-19 therapies sooner. In addition, it has leveraged its rapport with international regulators to share information on emerging technologies in the context of the rapid evolution of the virus while aligning and collaborating on regulatory and policy approaches. As new tests become available and approved for use in Canada, Health Canada works with provincial and territorial officials to acquire and distribute them.
There is also something to be said about biomanufacturing in this country. In order to secure a better supply of testing devices, it is essential that Canada increase its domestic biomanufacturing capacity. Investments in biomanufacturing capacity will reduce our reliance on imported products, strengthen our domestic industrial capacity and increase the resilience of our nation for years to come.
Budget 2021 made the government's commitment to the biomanufacturing sector clear with a $2.2-billion investment over the next seven years. The regulator is doing its part to support this as it recognizes that the strength of our regulatory system is an important consideration for companies looking to establish a Canadian presence. In fact, as of January 14 of this year, the Government of Canada purchased 30 million rapid tests from Artron Laboratories in Burnaby, British Columbia. These tests have been procured to fulfill immediate, emerging and long-term requirements.
Rapid test delivery is also very important. Rapid tests are proving to be another useful tool in our current response to the omicron variant. Thanks to a $3-billion investment through the safe restart agreement, public health units have extensive access to PCR tests and contact tracing resources, but rapid tests provide a further layer of protection by expanding testing into a broader range of environments, making testing even more accessible to Canadians and curtailing more quickly the spread of COVID-19.
I want to share the latest news on our pledge to deliver rapid tests free of charge to provinces and territories. The Government of Canada has negotiated with eight manufacturers to secure rapid antigen tests for the provinces and territories for the coming months. The Government of Canada has been buying and providing COVID-19 rapid tests free of charge to provinces and territories since October 2020 in line with its authorization of the first COVID-19 rapid test.
While the demand for COVID-19 rapid tests has increased significantly, the government has kept pace, being a reliable partner to provinces and territories, and that will continue. Since the start of the pandemic, we have procured 490 million tests, in fact.
In conclusion, testing is a critical part of Canada's response to the COVID-19 pandemic and how we adjust to everyday life. It allows us to identify outbreaks more quickly, isolate those who are sick, initiate contact tracing and support public health decisions at all levels of government. Equitable access to tests by all Canadians would help to limit the ongoing transmission of the omicron variant. It would help us to rebuild our economy and our lives. It would enable Canadians to know more quickly whether they are infected and to make choices that protect them and our communities.
As potential future waves of this pandemic come and go, we need to be able to weather the storm by using all the resources at our disposal. I trust that all hon. members of this House will agree that equitable access to testing would further protect all Canadians and help us through this pandemic. As a country we need the additional funding of $2.5 billion that Bill C-10 would provide to procure additional tests, and with members' support, we could make sure that every Canadian is in fact supported. We could unite on this point and unite in our common goal of being able to protect our health and to be able to rebuild our nation.
I will conclude by thanking health workers in my home community of London. I do not think that can be said enough. There will be disagreements in this House, and there are disagreements in this House, but one thing I hope we can unite on is recognizing the incredible contributions that they have made. Doctors, nurses and health workers of all kinds since the beginning of this pandemic have stood by members of our communities. London is a health care community and our identity in so many ways is based on that. We have world-class hospitals in our city.
Those constituents who continue to serve in hospitals, who continue to stand by my constituents, I cannot thank them enough. They know that this bill is very important, because while rapid tests are not a panacea as some think, they are a very important tool in combatting the virus. We know that from the health experts who have advised the government on the necessity of precisely this bill. That is why it is so important that we pass this. I hope we can pass it unanimously.
1235 words
All Topics
- Hear!
- Rabble!
- add
- star_border
- share
Mr. Speaker, first of all, words like “hypocrisy” have to be used very carefully, if at all, in this House. I think it is important to maintain basic decorum. I do not know the member very well, but I would hope he would live up to the honour of the office that he holds.
The health minister is doing exactly as we would hope. He is looking at the science and listening to the health experts. On the specific matter of what is happening at the border, our policy evolves. It evolves because as the pandemic evolves, so too does policy. That is something that has been clear throughout the pandemic. At every step the government has consulted with health experts before putting policy in place.
I wish that some in this House would believe in science, listen to it and listen to the health experts. We would be in much more agreement if that were the case.
160 words
All Topics
- Hear!
- Rabble!
- add
- star_border
- share
Mr. Speaker, I thank the member for his service. I do not know him that well, but I have always known him to be someone who cares very sincerely about the work and who has done a great deal for his constituents.
On this matter, we will disagree a bit. If we look at what the federal government has done since the onset of the pandemic, it responded very swiftly. It made historic efforts to put in place policy to deal with what is, I think we can all agree, the most difficult situation that has faced this country since the Second World War. Whether it is tourism operators or small or large businesses, we will continue to be there for Canadians as we have been throughout the pandemic, putting in place a number of measures, economic and otherwise, to meet the challenges head-on.
In my own community of London, we have been there whether for tourism operators or others. There is more we can do, of course, and we can look at that, but when it is all said and done, historians will have a lot to say on what has happened, and we will have favourable judgments in the years to come.
205 words
All Topics
- Hear!
- Rabble!
- add
- star_border
- share
